Cargando…
Disruptions in hepatic glucose metabolism are involved in the diminished efficacy after chronic treatment with glucokinase activator
Glucokinase activators are regarded as potent candidates for diabetes treatment, however, in clinical studies on patients with type 2 diabetes, a diminishing efficacy was observed after chronic treatment with them. The mechanism of this reduction has not been elucidated, and whether it is a class ef...
Autores principales: | Tsumura, Yoshinori, Tsushima, Yu, Tamura, Azusa, Kato, Hirotsugu, Kobayashi, Tsunefumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936481/ https://www.ncbi.nlm.nih.gov/pubmed/35312718 http://dx.doi.org/10.1371/journal.pone.0265761 |
Ejemplares similares
-
TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models
por: Tsumura, Yoshinori, et al.
Publicado: (2017) -
Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity
por: Park, Joo-Man, et al.
Publicado: (2015) -
Evolution of Hepatic Glucose Metabolism: Liver-Specific Glucokinase Deficiency Explained by Parallel Loss of the Gene for Glucokinase Regulatory Protein (GCKR)
por: Wang, Zhao Yang, et al.
Publicado: (2013) -
PAS Kinase deficiency alters the glucokinase function and hepatic metabolism
por: Pérez-García, A., et al.
Publicado: (2018) -
Brain glucose sensing, glucokinase and neural control of metabolism and islet function
por: Ogunnowo-Bada, E O, et al.
Publicado: (2014)